Therapeutic use of IL-2 to enhance antiviral T-cell responses in vivo
- PMID: 12692546
- DOI: 10.1038/nm866
Therapeutic use of IL-2 to enhance antiviral T-cell responses in vivo
Abstract
Interleukin (IL)-2 is currently used to enhance T-cell immunity but can have both positive and negative effects on T cells. To determine whether these opposing results are due to IL-2 acting differently on T cells depending on their stage of differentiation, we examined the effects of IL-2 therapy during the expansion, contraction and memory phases of the T-cell response in lymphocytic choriomeningitis virus (LCMV)-infected mice. IL-2 treatment during the expansion phase was detrimental to the survival of rapidly dividing effector T cells. In contrast, IL-2 therapy was highly beneficial during the death phase, resulting in increased proliferation and survival of virus-specific T cells. IL-2 treatment also increased proliferation of resting memory T cells in mice that controlled the infection. Virus-specific T cells in chronically infected mice also responded to IL-2 resulting in decreased viral burden. Thus, timing of IL-2 administration and differentiation status of the T cell are critical parameters in designing IL-2 therapies.
Similar articles
-
Efficacy of IL-2- versus IL-15-stimulated CD8 T cells in adoptive immunotherapy.Eur J Immunol. 2008 Oct;38(10):2874-85. doi: 10.1002/eji.200838426. Eur J Immunol. 2008. PMID: 18825743
-
Interleukin-10 plays an early role in generating virus-specific T cell anergy.BMC Immunol. 2007 Jun 14;8:8. doi: 10.1186/1471-2172-8-8. BMC Immunol. 2007. PMID: 17570849 Free PMC article.
-
Effector T-cell differentiation during viral and bacterial infections: Role of direct IL-12 signals for cell fate decision of CD8(+) T cells.Eur J Immunol. 2009 Jul;39(7):1774-83. doi: 10.1002/eji.200839093. Eur J Immunol. 2009. PMID: 19548244
-
IL-15 is superior to IL-2 in the generation of long-lived antigen specific memory CD4 and CD8 T cells in rhesus macaques.Vaccine. 2004 Sep 3;22(25-26):3510-21. doi: 10.1016/j.vaccine.2003.07.022. Vaccine. 2004. PMID: 15308379
-
Activated T lymphocytes from mice infected by lymphocytic choriomeningitis virus display high affinity IL-2 receptors but do not proliferate in response to IL-2.J Immunol. 1991 Dec 15;147(12):4333-7. J Immunol. 1991. PMID: 1753103
Cited by
-
Comparative Efficacy and Safety of Biological Agents in the Treatment of Lupus Nephritis: A Network Meta-Analysis.Pharmacology. 2023;108(1):17-26. doi: 10.1159/000527223. Epub 2022 Nov 3. Pharmacology. 2023. PMID: 36327917 Free PMC article.
-
CD8+ T Cell Fate and Function Influenced by Antigen-Specific Virus-Like Nanoparticles Co-Expressing Membrane Tethered IL-2.PLoS One. 2015 May 6;10(5):e0126034. doi: 10.1371/journal.pone.0126034. eCollection 2015. PLoS One. 2015. PMID: 25946103 Free PMC article.
-
T cell exhaustion during persistent viral infections.Virology. 2015 May;479-480:180-93. doi: 10.1016/j.virol.2014.12.033. Epub 2015 Jan 22. Virology. 2015. PMID: 25620767 Free PMC article. Review.
-
Effects of exogenous IL-2 administration on the homeostasis of CD4+ T lymphocytes.J Clin Immunol. 2004 Sep;24(5):503-14. doi: 10.1023/B:JOCI.0000040921.82055.91. J Clin Immunol. 2004. PMID: 15359109
-
Regulation of Effector and Memory CD8 T Cell Differentiation by IL-2-A Balancing Act.Front Immunol. 2018 Dec 20;9:2987. doi: 10.3389/fimmu.2018.02987. eCollection 2018. Front Immunol. 2018. PMID: 30619342 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources